Sanofi is set to acquire DR-0201 from Dren Bio for up to $1.9 billion, aiming to expand its autoimmune disease pipeline with ...

The Business Research Company Enjaymo Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The enjaymo ma ...

Sanofi has won FDA approval for its sutimlimab for cold agglutinin disease (CAD) at the second time of asking, becoming the first approved therapy for the rare blood disorder in the US.

Stocks surged on Friday, with the S&P 500 soaring 2.13% as investors welcomed a break from tariff-driven turmoil. The market ...

who developed COVID-19-associated cold agglutinin syndrome (CAS), a condition that resembles cold agglutinin disease (CAD) but is secondary to an underlying disorder. The report, published in the ...

Discover how CoolSculpting permanently eliminates stubborn fat without surgery. Learn about the procedure, recovery time and ...

When you have a rare disease such as cold agglutinin disease (CAD), you need to be diligent to avoid infections. One common infection I have seen over and over being discussed is a urinary tract ...

and cold agglutinin disease (CAD), with slightly earlier programmes in haematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) and amyotrophic lateral sclerosis ...

in patients with cold agglutinin disease. Financially, Annexon reported a strong balance sheet with cash and investments totaling $312 million, providing an operational runway into the second half ...

An ongoing open-label, single arm, POC study is evaluating ANX1502 in patients with cold agglutinin disease (CAD) for up to four weeks to evaluate tolerability, pharmacokinetics, pharmacodynamic and ...